Trial Information
Adult Intracranial Ependydomas : Prognostic and Diagnostic Factors Assessment and Molecular Characterization
Inclusion Criteria:
- Diagnosis later(posterior) than January, 1990
- Diagnosis previous to June, 2004
- Available postoperative MRI at the not dead patients during operating
- Diagnosis of EICA held(retained) after centralized second reading
- Absence of histories of radiotherapy and\or chemotherapy for a brain damage
Exclusion Criteria:
- Diagnosis previous to January, 1990
- Diagnosis later(posterior) than June, 2004 ·
- Diagnosis of EICA not held(retained) after centralized second reading
- Histories of radiotherapy and\or chemotherapy for a brain damage
Type of Study:
Interventional
Study Design:
Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic
Outcome Measure:
The primary objective is to identify a gene expression pattern associated with recurrence in adult intracranial ependymomas.
Outcome Time Frame:
3 years
Safety Issue:
No
Principal Investigator
philippe METELLUS
Investigator Role:
Principal Investigator
Investigator Affiliation:
Assistance Publique Hopitaux De Marseille
Authority:
France: Afssaps - Agence française de sécurité sanitaire des produits de santé (Saint-Denis)
Study ID:
2008-25
NCT ID:
NCT00920335
Start Date:
March 2009
Completion Date:
Related Keywords:
- Intracranial Ependymoma
- Adult intracranial ependymoma
- Ependymoma